Cognitive effects of COVID-19

Main Article Content

Ali Rıza Sonkaya
Büşra Sümeyye Polat
Bilgin Öztürk
Ülkühan Düzgün
Ömer Karadaş

Abstract

Objective: Neurological involvement can be seen in Covid-19 and cognitive functions can be affected negatively. There is not enough study and data about cognitive functions of patients followed with Covid-19 diagnosis. For this reason, the current study aims to examine the cognitive functions of patients diagnosed with Covid-19.


Material and Methods: Patients, who were hospitalized and followed-up with the diagnosis of Covid-19, were selected as consecutive. For evaluating cognitive functions, Montreal Cognitive Assessment (MoCA) test was performed to under 65-year-old participants, Standardized Mini- Mental State Exam (MMSE) test was performed to 65-year-old and older participants and Hospital Anxiety and Depression Scale (HADS) was performed to all participants.


Results: The study has consisted of 32 patients and 35 volunteers. The mean of MMSE scores was found to be lower in the patient group than the control group (p>0.05). The mean of MoCA scores was found to be lower in the patient group than the control group, and it was statistically significant (p<0.05). Also, in the sub-group analyzes that assessed the attention of the MoCA test group, the patient group scores were lower than the control group and it was statistically significant (p<0.05). Hospital anxiety scale scores of the patient group were found to be significantly higher than the control group (p<0.05).


Conclusion: The result of this study is showed the presence of cognitive impairment and increased anxiety in patients with Covid-19 who had no previous cognitive deficit. Therefore, it is important to evaluate the patients with Covid-19 in terms of mood and cognition in detail.

Downloads

Download data is not yet available.

Article Details

How to Cite
Sonkaya , A. R. ., Polat, B. S., Öztürk, B., Düzgün, Ülkühan, & Karadaş, Ömer. (2022). Cognitive effects of COVID-19. Medical Science and Discovery, 9(1), 61–65. https://doi.org/10.36472/msd.v9i1.667
Section
Research Article
Received 2022-01-09
Accepted 2022-01-17
Published 2022-01-24

References

Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci 2020; 41:1991-1995.

Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24(6):490- 502.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet 2020; 395(10223):497-506.

Sonkaya AR, Öztürk B, Karadaş Ö. Cerebral hemodynamic alterations in patients with Covid-19. Turk J Med Sci. 2021 Apr 30;51(2):435-439.

Needham EJ, Chou SH-Y, Coles AJ, Menon DK. Neurological implications of COVID- 19 infections. Neurocrit Care 2020; 32:667–671.

Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor, H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004; 203(2):631-637.

Nasreddine Z, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53:695-699.

Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3):189-198.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6):361-370.

Güngen C, Ertan T, Eker E, Yaşar R, Engin F. Standardize mini mental test’in Türk toplumunda hafif demans tanısında geçerlik ve güvenilirliği. Türk Psikiyatri Dergisi 2002; 13(4):273-281.

Mao L, Wang M, Chen S, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv.2020.

Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine 2020; 8(5): 475-481.

Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020; 323(14):1406-1407.

Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395(10223):507-513.

Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 2020.

Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology 2020; 77(6):683-690.

Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci 2020; 6(15):413.116832.

Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci 2020; 7(77):8-12.

Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS‐ CoV2 may play a role in the respiratory failure of COVID‐ 19 patients. J Med Virol 2020; 92(6):552-555.

Xiang YT, Yang Y, Li W, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. The Lancet Psychiatry 2020; 7(3):228-229.

Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020; 17(5):1729.

Özdin S, Bayrak Özdin Ş. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int J Soc Psychiatry 2020; 66(5):504–511.

Li S, Wang Y, Xue J, Zhao N, Zhu T. The impact of COVID-19 epidemic declaration on psychological consequences: a study on active Weibo users. Int J Environ Res Public Health 2020; 17(6):2032.

Speth MM, Singer-Cornelius T, Obere M, et al. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics. Otolaryngology Head and Neck Surgery. 2020 Jul;163(1):114-120.

Most read articles by the same author(s)